The Learning Portal will be under maintenance Saturday, 8 August between 6 AM and 6 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > Role of the CMC Regulatory Strategist in Due Diligence

Role of the CMC Regulatory Strategist in Due Diligence

Posted 01 July 2009 | By

A pharmaceutical or biologic due diligence exercise is a matchmaking process between two companies. It is undertaken to explore a potential deal driven by one company's need for another's medicinal product, medical device or technology, or in some cases, the other company in its entirety.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe